US Bancorp
FWP

US Bancorp’s Forward Pharma A/S American Depositary Shares FWP Stock Holding History

US Bancorp’s Portfolio FWP Stock Details FWP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-11
Closed -$2K – 3698
2016
Q3 		$2K Buy
+11
New +$1.55K ﹤0.01% 3396

Other funds holding FWP

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
AIM
Assured Investment Management New York $79.5M AUM 115.55% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
GCM
Gruss Capital Management New York $715M AUM 9.91% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
SH
Sandia Holdings Greenwich, Connecticut $213M AUM 29.35% 1-Year Est. Return

US Bancorp's FWP Position: Q4 2016 in Review

US Bancorp sold out of Forward Pharma A/S American Depositary Shares (FWP) in Q4 2016, closing a stake of 11 shares — an estimated $2K sold.

US Bancorp first reported a position in FWP in Q3 2016 and held it in 1 quarter. The position peaked at $2K in Q3 2016. 22 funds tracked by Wall St. Rank hold FWP as of Q4 2016.

  • US Bancorp reported no remaining Forward Pharma A/S American Depositary Shares position as of Q4 2016 after selling out during the quarter.
  • US Bancorp sold 11 Forward Pharma A/S American Depositary Shares shares in Q4 2016, an estimated $2K.
  • US Bancorp first reported a position in Forward Pharma A/S American Depositary Shares in Q3 2016 and held it in 1 quarter.
  • US Bancorp's Forward Pharma A/S American Depositary Shares position peaked at $2K in Q3 2016.
  • 22 funds tracked by Wall St. Rank held Forward Pharma A/S American Depositary Shares as of Q4 2016.

Based on US Bancorp's 13F filing for Q4 2016, filed 8 Feb 2017.